Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution

Author(s):  Alexander Kenneth S, Kaushik Sarita

Issue:  Mar/Apr 2004 - Overview of USP Chapter <797>
View All Articles in Issue

Page(s):  147-152

Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 1
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 2
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 3
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 4
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 5
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Page 6

Download in electronic PDF format for $75

Abstract:  Mexiletine hydrochloride is an orally active class I antiarrythmic agent. An extemporaneous solution of mexiletine hydrochloride was prepared for this study. Water was chosen as the vehicle due to the high solubility of the drug in water. Sorbitol, simple syrup and raspberry syrup were used as sweeteners in an attempt to mask the bitter taste of the drug. The solution was analyzed over 91 days of storage at five temperatures, ie, 4, 30, 40, 50 and 60°C. The sample was analyzed at 2, 6, 24 and 48 hours and then at 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 and 91 days at each designated temperature. The peak area for the mexiletine hydrochloride peak at time t = 0 was taken as 100%; and, accordingly, the percentages of intact drug remaining at each interval were calculated. The log percentage of the drug remaining was plotted against time (in days) at each temperature. The first-order constants for mexiletine hydrochloride at 4, 30, 40, 50 and 60°C were calculated to be -0.0007, -0.0009, -0.0010, -0.0011 and -0.0013, respectively. The Arrhenius plot was obtained by plotting the first-order degradation constants against the reciprocal of the absolute temperatures. The first-order degradation constant for mexiletine hydrochloride at 25°C was found to be 9.053 × 10-4(day-1). The energy of activation for the reaction was calculated to be -8663.88 J/mole. The shelf lives of the formulation at 4 and 25°C were found to be 173.3 and 115.5 days, respectively.

An attempt was made to identify and characterize any degradation products using the high-performance liquid chromatographic-mass spectrometry technique, as none of the degradation products were detected by ultraviolet analysis. However, this attempt was unsuccessful due to coating of the injection port with the sample, which might be due to crystallization of any of the excipients of the formulation under high temperatures. A degradation mechanism has been hypothesized based on either acid or base attack on the parent compound. The products from this degradation are presented.

Related Keywords: Alexander, Kenneth S, PhD, RPh, Kaushik, Sarita, Mexiletine hydrochloride solution, extemporaneous formulation of, Mexiletine hydrochloride solution, stability testing of

Related Categories: GERIATRICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, QUALITY CONTROL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution
Alexander Kenneth S
, Kaushik Sarita
Mar/Apr 2004
Pg. 147-152

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser
, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
Nov/Dec 2021
Pg. 523-527

Formulation and Stability of Solutions
Akers Michael J
Jan/Feb 2016
Pg. 41-45

Mexiletine Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2006
Pg. 225

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Formulation and Stability of Solutions
Akers Michael J
Mar/Apr 2016
Pg. 137-141

pH Stability of Injectable Fentanyl, Bupivacaine, or Clonidine Solution or a Ternary Mixture in 0.9% Sodium Chloride in Two Types of Polypropylene Syringes
Jappinen Annaliisa L
, Kokki H, Rasi A S, Naaranlahti Toivo J
Nov/Dec 2002
Pg. 471-474

Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Spennacchio Antonio
, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2023
Pg. 250-255

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations
Okeke Claudia C
, Medwick Thomas, Nairn Graham, Shaila Khuspe, Grady Lee T
Jul/Aug 2003
Pg. 313-319

Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Mar/Apr 2019
Pg. 157-162

Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
Jan/Feb 2009
Pg. 53-55

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2021
Pg. 324

Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021
Pg. 427-430

Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Spennacchio Antonio
, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
May/Jun 2023
Pg. 256-262

Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
McLellan Christine
, Ngo Van, Pasedis Sophia, Dohlman Claes H
Sep/Oct 2008
Pg. 456-459

Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie
, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Jul/Aug 2016
Pg. 347-350

Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
Mar/Apr 2000
Pg. 122-125

Return to Top